UTHR UNITED THERAPEUTICS Corp
Price Chart
Executive Summary
United Therapeutics insiders executed a cluster of derivative exercises and open-market sales over the past week, led by CEO Martine Rothblatt and CFO James Edgemon. The activity includes $5.7 million in exercised derivative value and $467,238 in open-market share sales, representing routine equity management rather than a material shift in sentiment.
Key Financial Metrics
Actionable Insight
Monitor for continued open-market selling above $1M; current activity reflects routine option monetization, not distress. No signal of fundamental change.
Key Facts
- CEO Martine Rothblatt exercised derivatives for 38,000 shares at $146.03 (total value $5.55M) and sold 440 shares for $229,936 in open market.
- CFO James Edgemon exercised derivatives for 20,000 shares at $135.42 (value $2.71M) and sold 200 shares for $103,657.
- Director Tommy Thompson exercised derivatives for 4,000 shares at $101.80 (value $407,200) and sold 275 shares for $147,845.
- Director Judy Olian sold 200 shares for $106,000.
- All derivative exercises were paired with non-cash transactions (code M at $0), consistent with standard option exercise mechanics.
- Total open-market sales: 1,115 shares valued at $467,238 over 7 days; average daily volume remains stable.
Financial Impact
$467,238 in open-market sales and $5.7M in derivative exercises over 7 days
Risk Factors
- Perception risk if media misinterprets derivative exercises as large-scale insider selling
- Potential for short-term price pressure if selling pace accelerates
Market Snapshot
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (19 trades, 7d window) | cluster-UTHR-1774557312992 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 9, 2026
today
|
Insider Cluster
| $553.04 awaiting T+1 | awaiting T+1 | — | $544.69 (−1.51%) |
|
Jun 5, 2026
4d ago
|
Insider Cluster
| $547.10 awaiting T+1 | awaiting T+1 | — | $544.69 (−0.44%) |
|
Jun 4, 2026
5d ago
|
Insider Cluster
| $547.10 awaiting T+1 | awaiting T+1 | — | $544.69 (−0.44%) |
|
Jun 4, 2026
5d ago
|
Insider Cluster
| $547.10 awaiting T+1 | awaiting T+1 | — | $544.69 (−0.44%) |
|
Jun 3, 2026
6d ago
|
Insider Cluster
| $547.22 $546.37 | ▼ −0.16% | ▲ +2.44% | $544.69 (−0.46%) |
|
May 29, 2026
11d ago
|
Insider Cluster
| $544.45 $539.91 | ▼ −0.83% | ▼ −0.98% | $544.69 (+0.04%) |
|
May 28, 2026
12d ago
|
Insider Cluster
| $553.34 $544.45 | ▼ −1.61% | ▼ −1.86% | $544.69 (−1.56%) |
|
May 27, 2026
13d ago
|
Insider Cluster
| $561.70 $553.34 | ▼ −1.49% | ▼ −1.73% | $544.69 (−3.03%) |
|
May 26, 2026
14d ago
|
Insider Cluster
| $567.74 $561.70 | ▼ −1.06% | ▼ −1.62% | $544.69 (−4.06%) |
|
May 26, 2026
14d ago
|
Insider Cluster
| $567.74 $561.70 | ▼ −1.06% | ▼ −1.62% | $544.69 (−4.06%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access